Viridian Therapeutics Stock Is Tanking. Why the Drop Is Linked to This Amgen Study.
安进(US:AMGN) Barrons·2026-04-07 00:10公司动态 - 安进公司宣布其针对甲状腺眼病的新疗法在3期临床试验中取得积极结果 [1] - Viridian Therapeutics公司目前也在开发针对该疾病的自身疗法 [1]
安进(US:AMGN) Barrons·2026-04-07 00:10安进(US:AMGN) Barrons·2026-04-07 00:10